These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 39244547

  • 1. Assessing the effectiveness of greater occipital nerve block in chronic migraine: a systematic review and meta-analysis.
    Mustafa MS, Bin Amin S, Kumar A, Shafique MA, Fatima Zaidi SM, Arsal SA, Rangwala BS, Iqbal MF, Raja A, Haseeb A, Jawed I, Hussien Mohamed Ahmed KA, Muhammad Sinaan Ali S, Varrassi G.
    BMC Neurol; 2024 Sep 07; 24(1):330. PubMed ID: 39244547
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients.
    Ercan M, Ertekin A.
    Ir J Med Sci; 2024 Aug 07; 193(4):2001-2009. PubMed ID: 38451438
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura?
    Palamar D, Uluduz D, Saip S, Erden G, Unalan H, Akarirmak U.
    Pain Physician; 2015 Aug 07; 18(2):153-62. PubMed ID: 25794201
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache.
    Chowdhury D, Kordcal SR, Nagane R, Duggal A.
    Cephalalgia; 2024 Oct 07; 44(10):3331024241291597. PubMed ID: 39415681
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of greater occipital nerve block on pain severity in migraine patients: A systematic review and meta-analysis.
    Tang Y, Kang J, Zhang Y, Zhang X.
    Am J Emerg Med; 2017 Nov 07; 35(11):1750-1754. PubMed ID: 28844531
    [Abstract] [Full Text] [Related]

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 12. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
    Dilli E, Halker R, Vargas B, Hentz J, Radam T, Rogers R, Dodick D.
    Cephalalgia; 2015 Oct 01; 35(11):959-68. PubMed ID: 25505035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Narrative review of peripheral nerve blocks for the management of headache.
    Stern JI, Chiang CC, Kissoon NR, Robertson CE.
    Headache; 2022 Oct 01; 62(9):1077-1092. PubMed ID: 36286600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.